2-Amino-5-iodopyrimidine → 5-[6-(4-Chloro-phenyl)-8-methyl-imidazo[1,2-a]pyridin-3-ylethynyl]-pyrimidin-2-ylamine
반응식
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:9]=[C:10]([CH3:19])[C:11]3[N:12]([C:14]([C:17]#[CH:18])=[CH:15][N:16]=3)[CH:13]=2)=[CH:4][CH:3]=1.[NH2:20][C:21]1[N:26]=[CH:25][C:24](I)=[CH:23][N:22]=1>>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[CH:9]=[C:10]([CH3:19])[C:11]3[N:12]([C:14]([C:17]#[C:18][C:24]4[CH:23]=[N:22][C:21]([NH2:20])=[N:26][CH:25]=4)=[CH:15][N:16]=3)[CH:13]=2)=[CH:6][CH:7]=1참가 물질
3
실험 절차
The title compound was prepared from 6-(4-chloro-phenyl)-3-ethynyl-8-methyl-imidazo[1,2-a]pyridine (example C.21) (267 mg, 1 mmol) and commercially available 2-amino-5-iodopyrimidine (221 mg, 1 mmol) according to general procedure II. Obtained as an off-white solid (60 mg, 17%). MS (ISP) 360.1 [(M+H)+], 362 [(M+2+H)+]; mp 263° C.
출처 및 근거
- ORD 기록
- ord-cb10a629027447c1a7c55bc8025efe1f
- 출처 데이터셋
- uspto-grants-2008_11